Libo Tang
State Key Laboratory Of Organ Failure Research, Key Laboratory Of Infectious Diseases Research In South China, Guangdong Provincial Key Laboratory For Prevention And Control Of Major Liver Diseases
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Correspondence to editorial on "Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2CD16hi subset linked to hepatitis B virus outcomes".
Journal: Clinical and molecular hepatology
Published: January 20, 2026
Correspondence to letter to the editor on "Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes".
Journal: Clinical and molecular hepatology
Published: January 20, 2026
Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes.
Journal: Clinical and molecular hepatology
Published: August 18, 2025
IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection.
Journal: Journal of translational medicine
Published: June 02, 2025
Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7⁺ Subset Linked to Antiviral Potential in Chronic HBV Infection.
Journal: Journal of medical virology
Published: April 21, 2025
The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination.
Journal: Experimental & molecular medicine
Published: December 23, 2024
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure.
Journal: Emerging microbes & infections
Published: October 29, 2024
IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
Journal: Journal of medical virology
Published: June 22, 2023
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC.
Journal: Hepatology (Baltimore, Md.)
Published: April 25, 2023
Causal associations between chronic hepatitis B and COVID-19 in East Asian populations.
Journal: Virology journal
Published: March 03, 2023
Peyer's patch-involved gut microbiota facilitates anti-HBV immunity in mice.
Journal: Virus research
Published: January 08, 2023
Last Updated: 09/26/2026